Current research progress of local drug delivery systems based on biodegradable polymers in treating chronic osteomyelitis

Chronic osteomyelitis is one of the most challenging diseases in orthopedic treatment. It is usually treated with intravenous antibiotics and debridement in clinical practice, which also brings systemic drug side effects and bone defects. The local drug delivery system of antibiotics has the charact...

Full description

Bibliographic Details
Main Authors: Yixiu Liu, Xu Li, A. Liang
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-11-01
Series:Frontiers in Bioengineering and Biotechnology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fbioe.2022.1042128/full
_version_ 1798015777104723968
author Yixiu Liu
Yixiu Liu
Xu Li
Xu Li
A. Liang
A. Liang
author_facet Yixiu Liu
Yixiu Liu
Xu Li
Xu Li
A. Liang
A. Liang
author_sort Yixiu Liu
collection DOAJ
description Chronic osteomyelitis is one of the most challenging diseases in orthopedic treatment. It is usually treated with intravenous antibiotics and debridement in clinical practice, which also brings systemic drug side effects and bone defects. The local drug delivery system of antibiotics has the characteristics of targeted slow release to the lesion site, replacing systemic antibiotics and reducing the toxic and side effects of drugs. It can also increase the local drug concentration, achieve sound bacteriostatic effects, and promote bone healing and formation. Currently, PMMA beads are used in treating chronic osteomyelitis at home and abroad, but the chain beads need to be removed after a second operation, inconveniences patients. Biodegradable materials have been extensively studied as optimal options for antibiotic encapsulation and delivery, bringing new hope for treating chronic osteomyelitis. This article reviews the research progress of local drug delivery systems based on biodegradable polymers, including natural and synthetic ones, in treating chronic osteomyelitis.
first_indexed 2024-04-11T15:40:14Z
format Article
id doaj.art-4b05197a55d041c481c7201c007499d6
institution Directory Open Access Journal
issn 2296-4185
language English
last_indexed 2024-04-11T15:40:14Z
publishDate 2022-11-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Bioengineering and Biotechnology
spelling doaj.art-4b05197a55d041c481c7201c007499d62022-12-22T04:15:51ZengFrontiers Media S.A.Frontiers in Bioengineering and Biotechnology2296-41852022-11-011010.3389/fbioe.2022.10421281042128Current research progress of local drug delivery systems based on biodegradable polymers in treating chronic osteomyelitisYixiu Liu0Yixiu Liu1Xu Li2Xu Li3A. Liang4A. Liang5Department of Orthopaedics, The Central Hospital Affiliated to Shenyang Medical College, Shenyang, ChinaShenyang Clinical Research Center for Hand and Foot, Shenyang, ChinaDepartment of Orthopaedics, The Central Hospital Affiliated to Shenyang Medical College, Shenyang, ChinaShenyang Clinical Research Center for Hand and Foot, Shenyang, ChinaDepartment of Orthopaedics, The Central Hospital Affiliated to Shenyang Medical College, Shenyang, ChinaShenyang Clinical Research Center for Hand and Foot, Shenyang, ChinaChronic osteomyelitis is one of the most challenging diseases in orthopedic treatment. It is usually treated with intravenous antibiotics and debridement in clinical practice, which also brings systemic drug side effects and bone defects. The local drug delivery system of antibiotics has the characteristics of targeted slow release to the lesion site, replacing systemic antibiotics and reducing the toxic and side effects of drugs. It can also increase the local drug concentration, achieve sound bacteriostatic effects, and promote bone healing and formation. Currently, PMMA beads are used in treating chronic osteomyelitis at home and abroad, but the chain beads need to be removed after a second operation, inconveniences patients. Biodegradable materials have been extensively studied as optimal options for antibiotic encapsulation and delivery, bringing new hope for treating chronic osteomyelitis. This article reviews the research progress of local drug delivery systems based on biodegradable polymers, including natural and synthetic ones, in treating chronic osteomyelitis.https://www.frontiersin.org/articles/10.3389/fbioe.2022.1042128/fullchronic osteomyelitislocal drug delivery systemssynthetic biodegradable polymersnatural biodegradable polymersmicro/nanoparticles
spellingShingle Yixiu Liu
Yixiu Liu
Xu Li
Xu Li
A. Liang
A. Liang
Current research progress of local drug delivery systems based on biodegradable polymers in treating chronic osteomyelitis
Frontiers in Bioengineering and Biotechnology
chronic osteomyelitis
local drug delivery systems
synthetic biodegradable polymers
natural biodegradable polymers
micro/nanoparticles
title Current research progress of local drug delivery systems based on biodegradable polymers in treating chronic osteomyelitis
title_full Current research progress of local drug delivery systems based on biodegradable polymers in treating chronic osteomyelitis
title_fullStr Current research progress of local drug delivery systems based on biodegradable polymers in treating chronic osteomyelitis
title_full_unstemmed Current research progress of local drug delivery systems based on biodegradable polymers in treating chronic osteomyelitis
title_short Current research progress of local drug delivery systems based on biodegradable polymers in treating chronic osteomyelitis
title_sort current research progress of local drug delivery systems based on biodegradable polymers in treating chronic osteomyelitis
topic chronic osteomyelitis
local drug delivery systems
synthetic biodegradable polymers
natural biodegradable polymers
micro/nanoparticles
url https://www.frontiersin.org/articles/10.3389/fbioe.2022.1042128/full
work_keys_str_mv AT yixiuliu currentresearchprogressoflocaldrugdeliverysystemsbasedonbiodegradablepolymersintreatingchronicosteomyelitis
AT yixiuliu currentresearchprogressoflocaldrugdeliverysystemsbasedonbiodegradablepolymersintreatingchronicosteomyelitis
AT xuli currentresearchprogressoflocaldrugdeliverysystemsbasedonbiodegradablepolymersintreatingchronicosteomyelitis
AT xuli currentresearchprogressoflocaldrugdeliverysystemsbasedonbiodegradablepolymersintreatingchronicosteomyelitis
AT aliang currentresearchprogressoflocaldrugdeliverysystemsbasedonbiodegradablepolymersintreatingchronicosteomyelitis
AT aliang currentresearchprogressoflocaldrugdeliverysystemsbasedonbiodegradablepolymersintreatingchronicosteomyelitis